HLA DQ LOCUS (CLASS II), EDTA BLOOD

image not found

NABL Cap Accredited     
HLA DQ Locus typing detects specific Class II human leukocyte antigen variants from EDTA blood. This test is important for organ and bone marrow transplantation, ensuring donor-recipient compatibility and reducing the risk of graft rejection. It also helps in evaluating susceptibility to autoimmune conditions such as celiac disease and type 1 diabetes. Metropolis Healthcare uses advanced molecular techniques to provide precise, high-resolution results for clinical and transplant decision-making 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 7,190.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: H0225

Frequently Asked Questions (FAQ's):

What does HLA DQ locus typing detect?
It identifies specific Class II HLA DQ alleles, aiding in transplant compatibility and autoimmune risk assessment.

Who should undergo this test?
Patients awaiting organ or bone marrow transplantation, and individuals being assessed for autoimmune disorders.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses molecular HLA typing techniques on EDTA blood to ensure accurate and high-resolution results.

What type of sample is required?
An EDTA-anticoagulated blood sample collected via routine venipuncture.

Is fasting required for this test?
No fasting or special preparation is necessary.

What does a positive result indicate?
It identifies specific HLA DQ alleles to support donor matching and assess autoimmune susceptibility.

Can this test guide transplant decisions?
Yes, it helps clinicians plan donor selection and post-transplant management.

How soon are results available from Metropolis Healthcare?
Results are generally available within 3–5 working days

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab